Hyperprolactinemia in Older Adults: Prevalence, Etiology, and Clinical Correlates in a Tertiary Geriatric Cohort
In a cross-sectional study of 210 older adults at a tertiary geriatric clinic, hyperprolactinemia was found in 6.7% of patients, predominantly caused by neuropsychiatric medications, though no significant association was observed with cognitive function or sarcopenia risk.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Inside the brain, a tiny gland known as the pituitary acts as a master switchboard, releasing hormones that tell other parts of the body what to do. One of these hormones is prolactin, a substance best known for its role in milk production after childbirth. However, prolactin circulates in everyone, and when its levels rise too high, a condition called hyperprolactinemia occurs. This elevation can happen for several reasons: a small, non-cancerous growth on the gland itself, a lack of signals from the brain to keep the hormone in check, or interference from medications that block the brain's natural braking system. While doctors often look for this issue in younger people with fertility problems or menstrual changes, the picture becomes much harder to see in older adults. In the elderly, classic signs like missed periods disappear, and other symptoms like sexual changes are often mistaken for the normal effects of aging. Yet, because older people frequently take multiple medications for various health issues, they may be exposed to drugs that accidentally raise prolactin levels, leaving a silent condition undetected.
Researchers at Hacettepe University in Turkey decided to shine a light on this hidden issue by studying a group of 210 older adults, all aged 65 or older, who were visiting a specialized geriatric clinic. Instead of waiting for patients to show symptoms, the team measured the prolactin levels in the blood of every single person who walked through the door. They found that nearly seven out of every hundred people in this group had elevated prolactin. The most striking discovery was that the vast majority of these cases were not caused by tumors or mysterious diseases, but by the very medications these patients were already taking. Specifically, drugs used to treat mental health conditions, such as certain antipsychotics and antidepressants, were the primary culprits. When the researchers looked closer, they saw that people with high prolactin were significantly more likely to be taking second-generation antipsychotics, a class of drugs often prescribed for dementia, depression, or behavioral issues.
The study also investigated whether these high hormone levels were linked to other common problems in aging, such as memory loss or muscle weakness. The team tested the participants' cognitive skills using a standard mental state exam and assessed their risk for sarcopenia, a condition involving the loss of muscle mass and strength. The results were clear: the presence of high prolactin did not seem to correlate with worse memory scores or a higher risk of muscle loss in this specific group. The researchers noted that while people with dementia or Parkinson's disease were more likely to have high prolactin, this appeared to be because these conditions often require the use of the very medications that raise hormone levels, rather than the diseases themselves directly causing the hormonal shift.
This work suggests that for older adults, particularly those managing neuropsychiatric conditions, a routine check of prolactin levels might reveal a side effect of their treatment plan rather than a new disease. The findings point to a need for doctors to be more aware that the drugs helping patients with their minds might be quietly altering their hormonal balance. While the study did not prove that these high levels cause immediate harm to memory or muscles, it highlights a frequent, drug-induced occurrence that is often overlooked in the complex medical lives of the elderly. The authors conclude that future research should follow these patients over time to see if identifying and managing these drug-induced changes leads to better health outcomes for this vulnerable population.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.